Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans Proteins | 19 | 2024 | 393 | 3.880 |
Why?
|
| Caenorhabditis elegans | 22 | 2024 | 613 | 3.660 |
Why?
|
| Synaptic Transmission | 10 | 2024 | 150 | 1.990 |
Why?
|
| GABAergic Neurons | 7 | 2023 | 33 | 1.750 |
Why?
|
| Receptors, Nicotinic | 11 | 2018 | 67 | 1.660 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2022 | 20 | 1.400 |
Why?
|
| Neuropeptides | 2 | 2021 | 82 | 1.300 |
Why?
|
| Motor Neurons | 8 | 2024 | 206 | 1.280 |
Why?
|
| Neuromuscular Junction | 8 | 2018 | 79 | 1.280 |
Why?
|
| Synapses | 4 | 2023 | 174 | 0.950 |
Why?
|
| Receptors, Cholinergic | 5 | 2023 | 21 | 0.950 |
Why?
|
| Animals, Genetically Modified | 7 | 2018 | 281 | 0.930 |
Why?
|
| Behavior, Animal | 7 | 2017 | 214 | 0.890 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 418 | 0.820 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2024 | 126 | 0.800 |
Why?
|
| Nicotinic Antagonists | 6 | 2005 | 19 | 0.750 |
Why?
|
| Axons | 2 | 2022 | 120 | 0.690 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 260 | 0.670 |
Why?
|
| Cholinergic Neurons | 2 | 2024 | 9 | 0.640 |
Why?
|
| Animals | 30 | 2024 | 19483 | 0.600 |
Why?
|
| Locomotion | 5 | 2021 | 108 | 0.590 |
Why?
|
| Acetylcholine | 7 | 2018 | 44 | 0.580 |
Why?
|
| Oviposition | 1 | 2017 | 3 | 0.580 |
Why?
|
| Nerve Net | 1 | 2017 | 94 | 0.540 |
Why?
|
| Dendrites | 1 | 2016 | 56 | 0.520 |
Why?
|
| Cholecystokinin | 1 | 2014 | 9 | 0.480 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2014 | 22 | 0.480 |
Why?
|
| Movement | 2 | 2013 | 145 | 0.460 |
Why?
|
| Dopamine | 1 | 2014 | 101 | 0.450 |
Why?
|
| Neural Inhibition | 1 | 2013 | 26 | 0.430 |
Why?
|
| Electrophysiology | 6 | 2006 | 89 | 0.380 |
Why?
|
| Signal Transduction | 6 | 2024 | 2875 | 0.370 |
Why?
|
| Motor Neuron Disease | 1 | 2010 | 29 | 0.360 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 68 | 0.350 |
Why?
|
| Cocaine | 2 | 2001 | 85 | 0.350 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 2006 | 7 | 0.320 |
Why?
|
| Neurons | 6 | 2016 | 853 | 0.320 |
Why?
|
| Muscles | 3 | 2006 | 170 | 0.310 |
Why?
|
| Patch-Clamp Techniques | 5 | 2013 | 125 | 0.290 |
Why?
|
| Receptors, AMPA | 4 | 2008 | 40 | 0.280 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2012 | 48 | 0.270 |
Why?
|
| Nicotine | 3 | 2005 | 109 | 0.260 |
Why?
|
| Receptors, FSH | 1 | 2024 | 9 | 0.240 |
Why?
|
| Muscle, Skeletal | 4 | 2013 | 668 | 0.230 |
Why?
|
| Mutation | 8 | 2014 | 2418 | 0.220 |
Why?
|
| Amino Acid Sequence | 8 | 2013 | 1576 | 0.220 |
Why?
|
| Nicotinic Agonists | 2 | 2000 | 39 | 0.220 |
Why?
|
| Piperidines | 2 | 2005 | 48 | 0.210 |
Why?
|
| Oocytes | 8 | 2009 | 189 | 0.200 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 75 | 0.200 |
Why?
|
| Dendritic Spines | 1 | 2022 | 12 | 0.200 |
Why?
|
| Presynaptic Terminals | 1 | 2022 | 38 | 0.200 |
Why?
|
| Electric Stimulation | 4 | 2013 | 139 | 0.200 |
Why?
|
| Escape Reaction | 2 | 2013 | 6 | 0.190 |
Why?
|
| Tyramine | 2 | 2013 | 9 | 0.190 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 219 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2019 | 835 | 0.170 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 12 | 0.170 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2013 | 79 | 0.170 |
Why?
|
| Xenopus laevis | 5 | 2009 | 66 | 0.170 |
Why?
|
| Mutant Proteins | 1 | 2019 | 103 | 0.160 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 473 | 0.160 |
Why?
|
| Brain Mapping | 1 | 2020 | 229 | 0.160 |
Why?
|
| Membrane Potentials | 3 | 2009 | 136 | 0.160 |
Why?
|
| Calcium Channels | 3 | 2008 | 95 | 0.160 |
Why?
|
| Decanoic Acids | 1 | 1998 | 2 | 0.160 |
Why?
|
| Molecular Sequence Data | 8 | 2008 | 1972 | 0.150 |
Why?
|
| Schizophrenia | 1 | 2020 | 256 | 0.150 |
Why?
|
| Neurosecretion | 1 | 2017 | 2 | 0.140 |
Why?
|
| Serotonergic Neurons | 1 | 2017 | 5 | 0.140 |
Why?
|
| Ion Channel Gating | 2 | 2009 | 40 | 0.140 |
Why?
|
| Serotonin | 1 | 2017 | 66 | 0.140 |
Why?
|
| Aldicarb | 2 | 2013 | 4 | 0.140 |
Why?
|
| Neurogenesis | 1 | 2017 | 59 | 0.140 |
Why?
|
| Nerve Regeneration | 1 | 2016 | 30 | 0.130 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2013 | 44 | 0.130 |
Why?
|
| Cations, Divalent | 1 | 1996 | 22 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 3 | 2013 | 350 | 0.130 |
Why?
|
| Regeneration | 1 | 2016 | 90 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2015 | 76 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1535 | 0.120 |
Why?
|
| Synaptic Vesicles | 2 | 2024 | 26 | 0.120 |
Why?
|
| Xenopus | 5 | 2006 | 53 | 0.120 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 14 | 0.120 |
Why?
|
| Rats | 5 | 2005 | 1901 | 0.120 |
Why?
|
| Dopaminergic Neurons | 1 | 2014 | 31 | 0.120 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2013 | 9 | 0.110 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 8 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2090 | 0.110 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 44 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 41 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 128 | 0.110 |
Why?
|
| Brain | 2 | 2020 | 1475 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 384 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 71 | 0.100 |
Why?
|
| Calnexin | 1 | 2010 | 5 | 0.090 |
Why?
|
| Calreticulin | 1 | 2010 | 3 | 0.090 |
Why?
|
| Paralysis | 1 | 2010 | 16 | 0.090 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 2 | 2012 | 3 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 357 | 0.090 |
Why?
|
| Ion Channels | 1 | 2010 | 86 | 0.090 |
Why?
|
| Necrosis | 1 | 2010 | 136 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2010 | 243 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 251 | 0.090 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2009 | 14 | 0.080 |
Why?
|
| Chloride Channels | 1 | 2009 | 27 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 265 | 0.080 |
Why?
|
| Calcium | 2 | 2019 | 550 | 0.080 |
Why?
|
| Muscle Contraction | 2 | 2024 | 198 | 0.080 |
Why?
|
| Avoidance Learning | 1 | 2008 | 22 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 333 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2009 | 576 | 0.080 |
Why?
|
| Mecamylamine | 2 | 1999 | 14 | 0.080 |
Why?
|
| Humans | 5 | 2023 | 58820 | 0.070 |
Why?
|
| Insect Proteins | 1 | 2006 | 79 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2006 | 169 | 0.070 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2005 | 4 | 0.060 |
Why?
|
| Levamisole | 1 | 2005 | 7 | 0.060 |
Why?
|
| Choline | 1 | 2005 | 21 | 0.060 |
Why?
|
| Heptanoic Acids | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cholinergic Antagonists | 1 | 2005 | 30 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 127 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 138 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2005 | 67 | 0.060 |
Why?
|
| Gene Expression | 2 | 2009 | 804 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 294 | 0.050 |
Why?
|
| Genome, Protozoan | 1 | 2003 | 5 | 0.050 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 16 | 0.050 |
Why?
|
| Interneurons | 1 | 2003 | 22 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 239 | 0.050 |
Why?
|
| Bungarotoxins | 1 | 2001 | 2 | 0.050 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2001 | 7 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2001 | 25 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 50 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2001 | 101 | 0.050 |
Why?
|
| Dimerization | 1 | 2001 | 145 | 0.050 |
Why?
|
| Time Factors | 2 | 2006 | 3544 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 678 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2000 | 51 | 0.040 |
Why?
|
| Kinetics | 2 | 2006 | 728 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2020 | 97 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 670 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 849 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 806 | 0.040 |
Why?
|
| RNA, Complementary | 1 | 1998 | 18 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 159 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1998 | 290 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 500 | 0.030 |
Why?
|
| Ganglionic Blockers | 1 | 1996 | 1 | 0.030 |
Why?
|
| Permeability | 1 | 1996 | 47 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 846 | 0.030 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2013 | 7 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2013 | 15 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 114 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 158 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2013 | 216 | 0.030 |
Why?
|
| Chromosome Pairing | 1 | 2012 | 5 | 0.030 |
Why?
|
| RNA | 1 | 1996 | 400 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 393 | 0.030 |
Why?
|
| Nervous System | 1 | 2012 | 69 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2012 | 90 | 0.020 |
Why?
|
| Female | 4 | 2005 | 30545 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2013 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 137 | 0.020 |
Why?
|
| Head Movements | 1 | 2009 | 8 | 0.020 |
Why?
|
| Neck Muscles | 1 | 2009 | 9 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2009 | 29 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 32 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2008 | 111 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 192 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2008 | 118 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1449 | 0.020 |
Why?
|
| Bees | 1 | 2006 | 4 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2006 | 40 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 292 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2006 | 18 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 1308 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 115 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 98 | 0.020 |
Why?
|
| Plasmids | 1 | 2006 | 279 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2006 | 253 | 0.020 |
Why?
|
| Ligands | 1 | 2006 | 420 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 162 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 661 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2006 | 366 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 569 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 489 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2011 | 0.010 |
Why?
|
| Mice | 2 | 2005 | 10184 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 162 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1090 | 0.010 |
Why?
|
| Male | 1 | 2005 | 27258 | 0.000 |
Why?
|